Annexon Stock

Annexon Financial Leverage

The Financial Leverage (Equity Multiplier) of Annexon (ANNX) as of Aug 13, 2026 is 1.31. In the previous year, Financial Leverage (Equity Multiplier) was 1.19 — a change of 9.81% (higher).

Financial Leverage

1.31

YoY

9.81%

Last updated:

Financial Leverage (Equity Multiplier) of Annexon is 2026 1.31 . Financial Leverage (Equity Multiplier) of Annexon was 2025 1.19 . It decreases by 9.81% higher compared to the previous year.
Access this data via the Eulerpool API

Annexon Stock analysis

What does Annexon do? Annexon Inc is a biopharmaceutical company based in South San Francisco, California. It was founded in 2011 by Doug Love, Ted Love, and Arnon Rosenthal, who had previously worked at major pharmaceutical companies such as Genentech and Novartis. The company's main goal is to develop new treatment options for neurodegenerative diseases, focusing on the development of drugs that target the autophagy process in cells to reduce damage to nerve cells and alleviate symptoms. Annexon Inc has two divisions, Annexon Biosciences and Annexon Clinical, with partnerships with renowned pharmaceutical companies to advance drug development. Its main product is ANX005, a therapeutic antibody protein that targets the role of the complement system in neurodegenerative diseases. Annexon Inc has received multiple awards for its work and innovations and has a dedicated team of scientists and executives committed to improving the lives of people with neurodegenerative diseases. Annexon is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Annexon stock

Financial Leverage (Equity Multiplier) of Annexon is 1.31 in 2026.

Financial Leverage (Equity Multiplier) of Annexon changed from 1.19 to 1.31, representing a 9.81% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Annexon since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Annexon with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Annexon

All Key Metrics — Annexon